Canaan transfers to Nasdaq Capital Market, seeks more time
Canaan Inc. has transferred its stock listing to the Nasdaq Capital Market and is seeking an additional 180-day period to regain compliance with Nasdaq's minimum bid price requirement. The company's stock has been trading below $1.00 for an extended period. This strategic move aims to provide Canaan with more flexibility as it continues to execute its long-term strategy, despite recent financial results falling short of expectations.
Here's Why Cboe Global's Revenue Growth Is More Than a Trading Story
Cboe Global Markets (CBOE) is experiencing revenue growth driven by diversified activities beyond traditional trading, including options, equities, futures, foreign exchange, digital assets, and market data. The company is notably expanding its recurring, non-transaction revenues and international operations. This strategic diversification, similar to peers Nasdaq and Intercontinental Exchange, contributes to greater resilience and has led management to raise its organic net revenue growth outlook.
Here's Why Cboe Global's Revenue Growth Is More Than a Trading Story
Cboe Global Markets' revenue growth is attributed to structural market trends, product innovation, and a diversified business model, with revenues rising by approximately 25% over the past two years. The company generates revenue from a variety of sources beyond traditional cash equity trading, including options, equities, futures, foreign exchange, digital assets, and high-margin market data services. Cboe's international expansion and recurring revenue streams contribute to its resilience and have led management to raise organic net revenue growth guidance to the low double-digit to mid-teens range.
Navient navigates listing shift as investor focus turns to student loan exposure
Navient's stock is drawing renewed attention following its transition to a Nasdaq listing. The company, which specializes in education-related loan management and servicing, continues to be evaluated by investors based on its core student loan business and its exposure to US borrowers. Key factors influencing investor perception include evolving student loan policies, borrower behavior, and the company's ability to adapt to regulatory changes.
Private-Public Crossover Strategy Delivers 27.45% Q2 Return for XOVR ETF Following SpaceX IPO
The ERShares Private-Public Crossover ETF (XOVR) achieved a 27.45% return in Q2 2026, largely due to its strategic investment in SpaceX prior to its June 12, 2026 IPO. This performance highlights the success of hybrid investment vehicles like XOVR, which allow retail investors to access late-stage private equity alongside public large-cap stocks. The fund used an innovative Shareholder Protection Plan to shield long-term investors during the IPO and has inspired derivative leveraged ETFs such as XOVL.
Marex Group (MRX) may sell senior unsecured index‑linked notes
Marex Group (MRX) has filed a prospectus for the potential sale of senior unsecured debt obligations, or "Notes," linked to various reference assets such as equity indices. These Notes will be direct, senior, unsecured obligations of Marex and will rank equally with other senior unsecured indebtedness, but they are not bank deposits or government-insured. The prospectus highlights various risks, including credit risk and potential conflicts of interest related to Marex's hedging activities, and notes that the specific terms of each offering will be detailed in a separate pricing supplement.
Innoviz appoints former Rafael defense CEO to board By Investing.com
Innoviz Technologies Ltd. has appointed Maj. Gen. (Ret.) Yoav Har-Even, former President and CEO of Rafael Advanced Defense Systems Ltd., to its Board of Directors. Har-Even brings extensive experience in defense technology and security, aligning with Innoviz's market expansion into security and defense applications alongside its automotive LiDAR offerings. The company also noted the resignation of James Sheridan from the board and highlighted recent strategic partnerships and market performance.
Trident founder converts US$8M debt as Nasdaq share-trading shift nears
Trident Digital Tech Holdings (Nasdaq: TDTH) Founder and CEO, Soon Huat Lim, plans to convert US$8 million of his outstanding debt into restricted Class B equity. This move, along with a proposed 240-for-1 Cayman-only share consolidation, aims to strengthen the company's balance sheet, reduce leverage, and facilitate its transition to direct Nasdaq ordinary-share trading. These initiatives are subject to shareholder approval at an Extraordinary General Meeting on July 8, 2026, and are intended to support Trident's enterprise AI commercialization strategy and global expansion.
World Investment Advisors Buys 17,500 Shares of Intercontinental Exchange Inc. $ICE
World Investment Advisors significantly increased its stake in Intercontinental Exchange (ICE) by purchasing an additional 17,500 shares in Q1, bringing its total holdings to 30,402 shares valued at approximately $4.78 million. This increase occurred despite recent insider selling by ICE directors. Analysts maintain a "Moderate Buy" rating for ICE, with an average price target of $188.58, following the company's Q1 earnings and revenue beats.
CDW Corp. stock leans on services and software demand
CDW Corp. stock is primarily driven by strong demand for its technology products and services across business and public sectors. The company's business model, focusing on repeat purchases and support services rather than single product cycles, provides investors with a clear insight into IT spending trends. Its diverse portfolio includes workplace devices, hybrid infrastructure, security, and cloud support, positioning it as a key player in procurement, integration, and lifecycle management for enterprise and institutional buyers.
ABJJIXX Stock Price and Chart — NASDAQ:ABJJIXX
This page provides an overview of the Barclays Bank PLC Point to Point Buffer Note ABJJIXX, listed on NASDAQ. It includes stock market information, identifiers like ISIN and CUSIP, and seasonal data. The article primarily serves as a financial data portal, indicating no trades and a closed market status for the featured stock.
424B2
This preliminary pricing supplement describes Autocallable Contingent Coupon Equity Linked Securities issued by Citigroup Global Markets Holdings Inc. and guaranteed by Citigroup Inc. These securities are linked to the performance of the Nasdaq-100 Index®, the Russell 2000® Index, and the S&P 500® Index, offering potential periodic contingent coupon payments but carrying significant risks including potential loss of principal and limited liquidity. The document details key terms such as coupon barriers, final barriers, automatic early redemption conditions, and hypothetical payment scenarios, along with comprehensive risk factors and federal tax considerations.
424B2
This preliminary pricing supplement describes Citigroup Global Markets Holdings Inc.'s "Autocallable Contingent Coupon Equity Linked Securities" linked to the Nasdaq-100, Russell 2000, and S&P 500 Indices, due April 18, 2030. These unsecured debt securities offer potential for periodic contingent coupon payments, but also carry risks including potential loss of principal, no coupon payments, and automatic early redemption depending on the worst-performing underlying index. The document details key terms, hypothetical examples of payments, and significant risk factors for investors.
Enterprise value to EBIT forward of Invesco Trust for Investment Grade Municipals – NASDAQ:XVGMX
This article focuses on the "Enterprise value to EBIT forward" metric for Invesco Trust for Investment Grade Municipals (NASDAQ: XVGMX). It appears to be a financial data page from TradingView, presenting a specific financial ratio for the investment trust without additional analysis or commentary. The content mainly lists navigation and copyright information related to the platform.
Enterprise value to revenue forward of Invesco Trust for Investment Grade Municipals – NASDAQ:XVGMX
This page provides financial information for Invesco Trust for Investment Grade Municipals (NASDAQ: XVGMX), focusing on its enterprise value to revenue forward ratio. The content is primarily a listing of financial data and market metrics provided by sources like ICE Data Services and FactSet. It indicates that the market was closed at the time of access with no trades.
ABGTUXX Stock Price and Chart — NASDAQ:ABGTUXX
This page on TradingView provides an overview of the ABGTUXX stock, which represents the Barclays Bank PLC Point to Point Fully Principally Protected Note. It includes basic information such as the stock's market status (currently closed with no trades), ISIN and CUSIP identifiers, and access to a full chart for historical data. The page also features a "Seasonals" section to identify recurring price trends over years.
ABKREXX Stock Price and Chart — NASDAQ:ABKREXX
This page provides an overview of the Barclays Bank PLC Capped Point to Point Fully Principally Protected Note, identified by the ticker ABKREXX on the Nasdaq Stock Market. It offers basic identifier information like ISIN, CUSIP, and FIGI, along with a "Seasonals" chart feature. The market is currently closed with no trades.
ABGHSXX Stock Price and Chart — NASDAQ:ABGHSXX
This page provides an overview of the ABGHSXX stock, which corresponds to the Barclays Bank PLC Capped Point to Point Fully Principally Protected Note. It indicates that the market is currently closed with no trades. The article also lists various identifiers for ABGHSXX, such as its ISIN and CUSIP, and mentions charting and seasonal analysis tools.
ABEDTXX Stock Price and Chart — NASDAQ:ABEDTXX
This page provides an overview of the Barclays Bank PLC Point to Point Buffer Note with the stock symbol ABEDTXX listed on NASDAQ. It includes basic identifying information like ISIN and CUSIP, and mentions market status (closed with no trades). The page also highlights a "Seasonals" feature for identifying recurring trends in price movements.
ABFMVXX Stock Price and Chart — NASDAQ:ABFMVXX
This page provides information on the ABFMVXX stock, which represents Barclays Bank PLC Point to Point Fully Principally Protected Note. It includes details such as its ISIN, CUSIP, and FIGI identifiers. The article notes that the market is currently closed with no trades.
ABJBBXX Stock Price and Chart — NASDAQ:ABJBBXX
This page provides an overview of the ABJBBXX stock, which is Barclays Bank PLC ITM Digital Buffer Note listed on the Nasdaq Stock Market. It shows that the market is currently closed with no trades. Key identifiers such as ISIN, CUSIP, and FIGI are also listed.
ABEXGXX Stock Price and Chart — NASDAQ:ABEXGXX
This page provides stock price and chart information for ABEXGXX, the Barclays Bank PLC Point to Point Fully Principally Protected Note, listed on NASDAQ. It includes an overview, community section, seasonal trends, and key identifiers like ISIN and CUSIP. The market is currently closed, showing no trades.
ABHZFXX Stock Price and Chart — NASDAQ:ABHZFXX
This page provides an overview of the Barclays Bank PLC Point to Point Buffer Note ABHZFXX (NASDAQ:ABHZFXX). It details identifiers such as ISIN, CUSIP, and FIGI, and offers a section for seasonal price movements. The article also mentions that the market is currently closed with no trades.
ABPIMXX Stock Price and Chart — NASDAQ:ABPIMXX
This page provides an overview of the Barclays Bank PLC Autocallable Contingent Interest Worst Of Barrier Note (ABPIMXX) listed on NASDAQ. It includes basic identifying information like ISIN and CUSIP, and mentions that market data is closed with no trades. The page also features a "Seasonals" section to identify recurring price trends over years.
ABFDCXX Stock Price and Chart — NASDAQ:ABFDCXX
This article provides details on the ABFDCXX Barclays Bank PLC Point to Point Fully Principally Protected Note, listed on the Nasdaq Stock Market. It includes basic information such as its ISIN, CUSIP, and FIGI identifiers. The page also mentions the availability of community insights and seasonal performance data, although no specific trading data is shown as the market is closed.
ABKQZXX Stock Price and Chart — NASDAQ:ABKQZXX
This page provides stock price and chart information for ABKQZXX, which is UBS AG London Branch Autocallable Contingent Interest Worst Of Barrier Note With Coupon Memory. It details the stock's performance, community insights, and seasonal trends, along with key identifiers like ISIN, CUSIP, and FIGI. The content emphasizes data integrity by citing ICE Data Services and FactSet for market and reference data.
ABGRRXX Stock Price and Chart — NASDAQ:ABGRRXX
This page provides an overview of the ABGRRXX stock, identified as Barclays Bank PLC Capped Point to Point Fully Principally Protected Note, listed on the Nasdaq Stock Market. It displays basic stock information, including ISIN, CUSIP, and FIGI identifiers, and notes that the market is currently closed with no trades. The platform also offers seasonal analysis tools and comparative charts for historical price movements.
AAXAWXX Stock Price and Chart — NASDAQ:AAXAWXX
This page provides an overview of the AAXAWXX stock, which represents a UBS AG London Branch Autocallable Contingent Interest Worst Of Barrier Note With Coupon Memory. It displays basic stock information, including its NASDAQ listing, ISIN, CUSIP, and FIGI identifiers. The page indicates that the market is closed with no current trades.
Goldman Sachs (GS) offers callable notes with contingent quarterly coupons
GS Finance Corp., guaranteed by The Goldman Sachs Group, Inc., is offering contingent income callable securities due July 13, 2028. These unsecured notes pay quarterly coupons only if the S&P 500®, Russell 2000®, and Nasdaq-100® indexes close at or above a 60% downside threshold on every business day of the observation period. The issuer can redeem the notes at par on specified coupon payment dates starting October 15, 2026, and investors face pro rata reduction based on the worst-performing index if any underlying index falls below its downside threshold at maturity.
Enterprise value to EBITDA forward of ANI Pharmaceuticals, Inc. – NASDAQ:ANIP
This article provides financial data for ANI Pharmaceuticals, Inc. (NASDAQ: ANIP), specifically focusing on its enterprise value to EBITDA forward. It indicates that the market was closed at the time of publication, and there were no trades. The content is primarily a data point from TradingView, alongside copyright and product information.
Hsbc Holdings PLC Sells 46,079 Shares of Nasdaq, Inc. $NDAQ
HSBC Holdings PLC reduced its stake in Nasdaq, Inc. by 3.6% in the fourth quarter, selling 46,079 shares and retaining 1,225,879 shares valued at $119.3 million. Nasdaq reported strong quarterly earnings, beating estimates with $0.96 EPS and $2.14 billion in revenue, a 13.7% year-over-year increase, and subsequently raised its quarterly dividend to $0.31 per share. Analysts maintain a "Moderate Buy" consensus rating with an average price target of $107.54 for Nasdaq.
PAVmed gets 180-day extension to regain Nasdaq listing compliance
PAVmed Inc. has received a 180-day extension from Nasdaq to regain compliance with its minimum bid price requirement. The company now has until December 30, 2024, to meet the requirement where its common stock must maintain a closing bid price of at least $1.00 for ten consecutive trading days. PAVmed is exploring available options, including a reverse stock split, to address this deficiency.
Callan JMB Faces Nasdaq Minimum Bid Price Noncompliance
Callan JMB Inc. (CJMB) has received a notice from Nasdaq regarding noncompliance with the minimum bid price requirement, as its stock traded below $1.00 for 30 consecutive business days. The company has an initial 180-day period to regain compliance by having its stock close at or above $1.00 for at least ten consecutive business days. Failure to meet this standard could lead to delisting, although Callan JMB may explore options like a reverse stock split or seek an extension.
Amazon stock beats Nasdaq before holiday break; focus on Leo, Prime Day data next week
Amazon (NASDAQ:AMZN) stock outperformed the Nasdaq composite before the Independence Day holiday, closing up 0.4% versus Nasdaq's 0.8% loss. The market will closely watch two key data points next week: the upcoming Prime Day sales figures, with average order value down despite increased online spending, and continued spending on the Leo satellite project, which is nearing initial service with 394 satellites in orbit. Analysts remain largely bullish on Amazon, with a strong buy consensus and an average target price significantly above its current trading price.
QQQM - Invesco NASDAQ 100 ETF Earnings
This article provides a detailed financial overview of the Invesco NASDAQ 100 ETF (QQQM), including its last closing price, percentage change, and various performance metrics. It lists key data such as dividend information, expense ratio, asset allocation, and returns over different periods. The article also highlights the fund's AUM, 52-week high and low, and other technical indicators.
Cboe Global Stock Lags Industry, Trades at a Discount: Time to Buy?
Cboe Global Markets (CBOE) stock has underperformed its sector but boasts a strong market position in the US options market and a diversified business model with recurring revenues. The company exhibits attractive valuation compared to its industry, solid growth projections including a 16.8% expected long-term earnings growth rate, and optimistic analyst sentiment, making it a "Strong Buy" according to Zacks Investment Research.
Trupanion stock reflects a thin news tape. The insurer stays tied to pet care demand.
Trupanion Inc. (ISIN US89832Q1094) operates a subscription-based pet insurance model focusing on veterinary coverage for cats and dogs. The company's performance is driven by pet owner demand, claims behavior, and veterinary cost trends, emphasizing policy renewals and underwriting discipline. Investors monitor subscriber growth, margins, and claims costs, with the company's official investor materials providing the most reliable operational updates.
Inmune Bio Inc outlines its immunotherapy focus as shares trade on Nasdaq
Inmune Bio Inc. (INMB) is a clinical-stage biotechnology company listed on Nasdaq, specializing in immunotherapies that modulate the innate immune system for treating cancer and neurodegenerative diseases. The company's strategy involves harnessing the body's natural defenses to fight illness, with its pipeline focused on advancing treatments through clinical trials. As a clinical-stage firm without commercial products, Inmune Bio relies on external financing and strategic collaborations to fund its research and development efforts.
Cboe Global Stock Lags Industry, Trades at a Discount: Time to Buy?
Cboe Global Markets (CBOE) stock has lagged the sector but trades at a discount compared to its industry. The article highlights CBOE's dominant position in the options market, diversified business model, strong recurring revenues, and strategic acquisitions as key drivers for growth. With optimistic analyst sentiment, solid growth projections, and an affordable valuation, the stock is considered a strong buy.
Nasdaq's New Breed: Eightco Reveals Massive Holdings — OpenAI Stake, 283 Million WLD Tokens, Total Assets Touted at $386 Million
Eightco Holdings (ORBS), a Nasdaq-listed company, disclosed its asset portfolio as of July 1, 2026, totaling $386 million. The portfolio features a substantial indirect equity stake in OpenAI worth $90 million, 283 million Worldcoin (WLD) tokens (8.1% of circulating supply), and exposure to the creator economy through Beast Industries (MrBeast). Eightco aims to offer investors indirect exposure to AI, digital identity verification, and the creator economy through a single stock.
Cboe Global Stock Lags Industry, Trades at a Discount: Time to Buy?
Cboe Global Markets (CBOE) stock has underperformed the sector and S&P 500 year-to-date but is trading at a discount compared to its industry. The company boasts a diversified business, recurring revenues, and strong growth prospects driven by strategic acquisitions and digital asset investments. Analysts are optimistic about CBOE, giving it a Zacks Rank #1 (Strong Buy) due to its affordable valuation and solid projected growth.
Jefferies (JEF) prices autocallable notes linked to worst‑performing index
Jefferies Financial Group Inc. has priced Senior Autocallable Contingent Coupon Barrier Notes, which are linked to the worst-performing of the Nasdaq-100, Russell 2000, and S&P 500 indices. These notes, with a stated principal of $1,000, offer monthly contingent coupons and are autocallable if the worst-performing underlying meets its call value. At maturity, investors either receive full principal or face 1:1 downside exposure to the worst-performing index if it falls below an 80% threshold.
Price to book forward of Intellicheck, Inc. – NASDAQ:IDN
This article provides the "Price to book forward" for Intellicheck, Inc. (NASDAQ: IDN). It appears to be a financial data snippet from TradingView, indicating a specific financial metric for the company. The content itself is very brief and embedded within what seems to be a larger financial data platform interface.
TD Bank (TD) offers callable, index‑linked notes with 8.65% contingent coupon
The Toronto-Dominion Bank is offering Callable Contingent Interest Barrier Notes linked to the Nasdaq-100, Russell 2000, and S&P 500 indexes, with a contingent interest rate of approximately 8.65% per annum. These notes have a principal of $1,000, a maturity date of July 3, 2031, and can be called by TD monthly starting from the twelfth contingent interest payment date. Investors face principal loss if not called and the least performing index falls below a 60% barrier at maturity, and payments are subject to TD’s credit risk.
Restricted stock notice: KLAC (NASDAQ: KLAC) 27,701 shares
KLA Corporation (NASDAQ: KLAC) has filed a Form 144/A notice reporting the restricted stock vesting of 27,701 shares of common stock, with an event date of June 30, 2025. The filing occurred on July 2, 2026, and lists Fidelity Brokerage Services LLC as the broker. This type of filing informs the market about shares becoming fully owned and potentially tradable, which is relevant for investors tracking insider incentives and potential changes in stock supply.
Barinthus Biotherapeutics (BRNS) wins more time to meet Nasdaq $1 bid rule
Barinthus Biotherapeutics (BRNS) has been granted an additional 180 days, until December 28, 2026, by Nasdaq to regain compliance with the minimum $1.00 per share bid price requirement. In connection with this extension, its American Depositary Shares were transferred from the Nasdaq Global Market to the Nasdaq Capital Market. The company is evaluating options, including a potential reverse stock split, to restore compliance and avoid delisting.
First Trust Announces Changes to Investment Strategies, Name and Other Related Matters for First Trust RiverFront Dynamic Emerging Markets ETF
First Trust Advisors L.P. announced changes to the First Trust RiverFront Dynamic Emerging Markets ETF (RFEM), effective around September 14, 2026. The ETF will be renamed First Trust Active Factor Emerging Markets ETF (AFEM) and will shift to a multi-factor quantitative strategy focusing on value, momentum, quality, and low volatility, investing primarily in emerging market equity securities. Additionally, its annual management fee will decrease from 0.95% to 0.85%, and the Fund will no longer have a sub-advisor.
Invesco NASDAQ free cash flow achievers ETF declares quarterly distribution of $0.0311
The Invesco NASDAQ Free Cash Flow Achievers ETF (QOWZ) has announced a quarterly distribution of $0.0311 per share. This declaration provides investors with information regarding the ETF's upcoming payout.
QQQM - Invesco NASDAQ 100 ETF Revenue Breakdown
This article provides a detailed financial breakdown of the QQQM - Invesco NASDAQ 100 ETF. It includes key metrics such as last close price, dividend information, expense ratio, asset under management (AUM), performance across various timeframes, and volatility data. The ETF, which tracks the Nasdaq 100 Index, recorded a 1-year return of 31.00% and holds 108 total assets.
RenovoRx Receives Nasdaq Delisting Notice: Key Details from Latest 8-K Filing
RenovoRx, Inc. (RNXT) has received an extension from Nasdaq until December 28, 2026, to regain compliance with the minimum bid price requirement of $1.00. The company initially had until June 30, 2026, but was granted an additional 180 days. This extension provides temporary relief, but the risk of delisting remains significant if the stock fails to meet the bid price requirement, which could negatively impact its liquidity and valuation.
